How the Rising Dollar May Impact Your Portfolio - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Aug 26, 8:03PM CDT
These companies could be impacted if the dollar continues to rise.
Merck, Pfizer combining drugs
at Investor's Business Daily - Tue Aug 26, 5:45PM CDT
Merck (MRK) will study its new immunotherapy drug candidate, brolizumab, in combination with Pfizer's (PFE) already-approved Xalkori to treat metastatic lung cancer. The trial is expected to start next year. In Feb. the drug giants announced they...
Most active New York Stock Exchange-traded stocks
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Final Glance: Pharmaceuticals companies
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
HCP Boasts Of 29 Years Of Dividend Increases
at Investor's Business Daily - Tue Aug 26, 4:57PM CDT
HCP (HCP) is a real estate investment trust that invests in four health-care sectors: senior housing; post-acute/skilled nursing facilities; life sciences; and medical offices and hospitals. The company manages, acquires, develops and sells...
After Yesterday's Rally of 1.04% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:42PM CDT
Pfizer (NYSE
Pfizer Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:41PM CDT
Pfizer (NYSE
Economic Data Fuel Another All-Time High For S&P 500
at Investor's Business Daily - Tue Aug 26, 2:36PM CDT
A big jump in durable goods orders and a strong reading on consumer confidence from the Conference Board fueled modest gains for the stock market Tuesday. The Dow Jones industrial average led the way, rising 0.3%. Exxon Mobil (XOM), UnitedHealth...
Why Merck (MRK) Stock Is Gaining Today
at The Street - Tue Aug 26, 2:14PM CDT
Merck (MRK) shares are climbing after the company revealed a collaborative effort with Pfizer on lung cancer treatment trials.
Ethical Pharmaceuticals Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
PRWeb - Tue Aug 26, 1:03PM CDT
Ethical pharmaceuticals or prescription drugs are those licensed drugs that are regulated by various legislation to require a written medical prescription before it can be procured. An ethical pharmaceutical product is only sold by pharmacists when it has been approved by a written medical prescription from a registered medical practitioner. The term prescription drugs or ethical pharmaceutical is usually used to distinguish the products from over-the-counter drugs--drugs that can be obtained without a written medical prescription. However, varied jurisdictions have varied definitions of what constitutes an ethical pharmaceutical. At present, ethical pharmaceuticals market is highly profitable as well as a risky market venture. The market is expected to be profitable owing to the upcoming patent expiries of many blockbuster drugs; and risky because of the involvement of many established and multinational companies who have built a global recognition for their safe and effective products.
Midday Glance: Pharmaceuticals companies
AP - Tue Aug 26, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Merck, Pfizer Combining Drugs In Lung Cancer Study
at Investor's Business Daily - Tue Aug 26, 11:07AM CDT
Big pharma Merck (MRK) will study its hot new immunotherapy drug candidate in combination with rival Pfizer's currently approved Xalkori to treat metastatic lung cancer, the two firms announced Tuesday. The trial of pembrolizumab and Xalkori,...
Should Gilead Sciences, inc. Fear This New Competitor Drug?
Todd Campbell, The Motley Fool - Motley Fool - Tue Aug 26, 10:41AM CDT
According to ViiV Healthcare -- GlaxoSmithKline , Pfizer , and Shionogi 's HIV drug consortium -- one in three Americans fails to take their HIV medication as prescribed. That means hundreds of thousands of patients aren't receiving the medicine...
Active Pharmaceutical Ingredients Global Market - Forecast to 2020
M2 - Tue Aug 26, 10:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53c3t/active) has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Active Pharmaceuticals Ingredients by Synthesis 5. Active Pharmaceuticals Ingredients by Therapeutic Applications 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/n53c3t/active
Early Glance: Pharmaceuticals companies
AP - Tue Aug 26, 10:12AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Pfizer (PFE) Breaks Through Resistance at $29.03
Comtex SmarTrend(R) - Tue Aug 26, 8:58AM CDT
Shares of Pfizer (NYSE
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Business Wire - Tue Aug 26, 7:00AM CDT
Pfizer Inc. (NYSE
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas